What is lactoferrin
80 kDa iron-binding glycoprotein · present in colostrum, breast milk, mucosa. Apo-form (no Fe) and holo-form (Fe-saturated). Bovine bLF is canon supplementation source.
Iron-binding glycoprotein · alternative to ferrous sulfate better tolerated gastrointestinally. Paesano 2024 meta: gestational anemia equivalent repletion with −67% GI side effects vs sulfate. Mucosal immunomodulation + antiviral COVID/HSV.
4Lactoferrin appears in 4 protocols personalizable→80 kDa iron-binding glycoprotein · present in colostrum, breast milk, mucosa. Apo-form (no Fe) and holo-form (Fe-saturated). Bovine bLF is canon supplementation source.
Lactoferrin (LF) is an 80 kDa glycoprotein of the transferrin family that binds iron with very high affinity (Kd ≈10⁻²⁰ M, 260× transferrin). Present in colostrum (~7 g/L first milk), mature breast milk (~1-2 g/L), tears, saliva, intestinal/respiratory mucosa, secondary neutrophils.
Used supplement: bovine lactoferrin (bLF) · 70% sequence homology with human hLF · clinically interchangeable. Two forms: apo-LF (iron-unsaturated, <5% Fe) and holo-LF (Fe-saturated). Apo-LF preferred for anemia (leaves free Fe-binding capacity in gut) and antimicrobial (deprives pathogens of Fe). Mechanisms: anemia repletion via LfR receptor on intestinal enterocyte (Fe-LF transcytosis) without sulfate GI effects · NK + Tcell + sIgA immunomodulation · direct antimicrobial (pathogenic Fe sequestration + bacterial membrane permeabilization via lactoferricin peptide) · antiviral (HSV, COVID-19, rotavirus adhesion blockade). Stable up to pH 3 stomach in apo-form · partial gut digestion releases antimicrobial lactoferricin peptide.
5 pivotal studies · coverage of gestational anemia, general ID anemia, immunomodulation, antiviral COVID, oncological mucositis.
| Study | Finding | Hallmarks |
|---|---|---|
Lactoferrin and gestational anemia Paesano · BJN 2024 meta | Meta-analysis 12 RCTs n=2,184 pregnant women with ID anemia · bLF 100-200 mg × 2/d × 30-60 days · Hb +1.8 g/dL (non-inferior to sulfate), GI side effects −67% (nausea, constipation, dyspepsia). | AnemiaHb |
Lactoferrin antiviral COVID-19 Campione et al · Nutrients 2024 update | RCT n=256 mild-moderate COVID-19 · apo-LF 100 mg × 2/d × 10 days · CT recovery −22%, IL-6 −31%, ferritin −28%. Mechanism: ACE2/spike blockade. | COVID-19Antiviral |
Lactoferrin oncological mucositis Bertuccioli et al · Cancers 2024 | RCT n=128 head-neck chemo/RT · topical/oral bLF 100 mg × 3/d × treatment · grade ≥3 mucositis −47%, pain days −2.8. | MucositisOncology |
Lactoferrin H. pylori adjuvant Zou et al · Helicobacter 2024 update | Meta-analysis 8 RCTs n=1,108 · bLF 200-400 mg/d adjuvant to triple therapy × 7-14 days · eradication +12% (OR 1.45), GI adverse −38%. | H.pyloriAdjuvant |
My Protocol generates 3 personalized plans with exact form, dose and combos based on your profile. No commitment.
López-Otín 2023 maps 12 aging hallmarks · direct impact (gold-deep) and indirect (sage).
4-phase protocol · bovine apo-LF canon · empty stomach for better absorption · optimal anemia stack with Vit C.
First-line alternative to ferrous sulfate (GI intolerance). Paesano 2024 Hb +1.8 g/dL · GI side effects −67%. Under obstetric supervision · monitor ferritin/Hb at 4 wk.
Non-pregnant adults intolerant to sulfate. Stack with Vit C 500 mg to boost absorption. Monitor ferritin every 8 wk. Maintain 3 months post-repletion until ferritin saturation >30 ng/mL.
Apo-LF blocks ACE2/spike + reduces IL-6. Campione 2024 CT recovery −22%. Useful for seasonal respiratory prophylaxis · post-exposure. Liposomal form boosts bioavailability.
Bertuccioli 2024 grade ≥3 mucositis −47%. Under functional oncology. Dissolve granules in warm water · rinse + swallow. Continue 1 wk post-last session.
Apo-LF (Fe-unsaturated) canon for anemia + antimicrobial · Liposomal boost oral bioavailability · Holo-LF specific niche.
3 tiers · bovine apo-LF canon · verified CFU + lactoferricin peptide content.
Dose: 250 mg bovine apo-LF/capsule
Form: Bovine apo-LF <5% Fe · validated EDTA desaturation process
Cert.: GMP USA · cGMP · USP · LC-MS glycoprotein ID
Fillers: Plant-based HPMC capsule. Lactose-free (residues <1 ppm), casein-free.
Dose: 300 mg bovine apo-LF/capsule
Form: Bovine apo-LF · fresh milk microfiltration process
Cert.: GMP USA · NSF · validated lactoferricin peptide viability
Fillers: Plant-based HPMC capsule + rice powder. Lactose-free.
Dose: 250 mg bovine apo-LF/capsule
Form: Standard bovine apo-LF
Cert.: GMP USA · NPA A-rated · tested
Fillers: HPMC capsule + rice powder. Lactose-free, gluten-free, vegan-capsule.
My Protocol recommends form + brand + exact dose based on your age, budget and biomarkers. No commitment · 3 minutes.
3 biomarkers · iron-kinetic panel + Hb + mucosal sIgA.
Serum ferritin. Optimal range: 50-150 ng/mL men · 50-100 ng/mL premenopausal women. <30 deficient. Rises with lactoferrin 8-12 wk repletion. Cost ~€10-15.
Hemoglobin (Hb) + hematocrit. Optimal range: 13.5-17 g/dL men · 12-15.5 g/dL women. Rises ~1.8 g/dL with LF in 30-60 days gestational anemia (Paesano). Routine CBC ~€5-10.
Transferrin + saturation. Saturation >20% normal · <16% suggestive of ID. Fe transport marker. Useful in complete iron-kinetic panel + ferritin. ~€15-20.
Ferritin + Hb + transferrin + saturation + reticulocytes + MCHC + RDW. Complete anemia panel · useful baseline + 8-12 wk post-LF. We verify clinics in-situ.
Excellent safety profile · specific clinical contexts: milk allergy · hemochromatosis · high dose pregnancy.
4 combos · focus on anemia repletion + immunity + antimicrobial + antiviral.
Optimal anemia combo. bLF improves enterocyte absorption via LfR + bisglycinate chelate well-tolerated. First-line stack for sulfate intolerance.
Vit C 500 mg reduces Fe³⁺→Fe²⁺ + boosts enterocyte absorption. Canon anemia repletion stack.
Gut stack + H.pylori adjuvant. Zou 2024 LF + Szajewska 2024 boulardii · combo H.pylori eradication + triple therapy GI adverse reduction.
Antiviral combo · quercetin (zinc-ionophore + COVID) + lactoferrin (ACE2/spike blockade). Campione 2024 + quercetin studies.
8 real questions · answers based on Paesano + Campione + Bertuccioli + Zou literature.
Supplements · treatments · biomarkers for your complete protocol.
My Protocol cross-references +500 clinical parameters and generates 3 personalized plans with supplements, treatments and biomarkers adapted to your case.
Generate My Protocol free →This guide is educational · does not constitute personalized medical advice. Before supplementing, consult a healthcare professional. Some links are affiliate · commission does not affect the price you pay or condition our selection. No sponsorships. No advertorials.